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ABSTRACT
PURPOSE: To investigate if the ethyl-pyruvate solution could reduce mortality in AP and/or diminish the acute lung injury. 
METHODS: Forty male rats, weighing between 270 to 330 grams were operated. An experimental model of severe AP by injection 
of 0.1ml/100g of 2.5% sodium taurocholate into the bilio-pancreatic duct was utilized. The rats were divided into two groups of ten 
animals each: CT - control (treatment with 50ml/kg of Ringer’s solution, intraperitoneal) and EP (treatment with 50ml/kg of Ringer 
ethyl- pyruvate solution, intra-peritoneal), three hours following AP induction. After six hours, a new infusion of the treatment solution 
was performed in each group. Two hours later, the animals were killed and the pulmonary parenchyma was resected for biomolecular 
analysis, consisting of: interleukin, myeloperoxidase, MDA, nitric oxide, metalloproteinases and heat shock protein. In the second part 
of the experiment, another, 20 rats were randomly divided into EP and CT groups, in order to evaluate a survival comparison between 
the two groups. 
RESULTS: There were no significant differences in IL-1B,IL-10, MMP-9, HSP70, nitric oxide, MPO, MDA (lipidic peroxidation) 
concerning both groups. The levels of IL-6 were significantly diminished in the EP group. Furthermore, the MMP-2 levels were also 
reduced in the EP group (p<0.05). The animals from the EP treatment groups had improved survival, when compared to control group 
(p<0.05). 
CONCLUSION: The ethyl-pyruvate diminishes acute lung injury inflammatory response in acute pancreatitis and ameliorates survival 
when compared to control group, in the experimental model of necrotizing acute pancreatitis.
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Introduction
Mild acute pancreatitis has a low mortality rate, but 
patients with severe acute pancreatitis (SAP) are more likely 
to have complications and a much higher death rate. Severe 
pancreatic injury occurs in 20% of the patients, and 15% to 25% 
of these patients will end in fatality1,2. The amplifying effects of 
inflammatory and oxidative impairment often lead to SAP-induced 
complications, which are often regarded as hallmarks of SAP and 
herald a noted poor outcome. Since respiratory dysfunction is the 
main cause of death in patients with SAP, elucidating the critical 
period of acute pancreatitis-associated lung injury (APALI) is 
clinically important. Even though the pathogenesis of APALI has 
been studied worldwide in the past years, efforts of researchers 
mainly focused on inflammatory factors3.
Current studies have shown that some inflammatory 
mediators play an important role in SAP complicated with multiple 
organ injury4-6. This suggests an intricate balance between localized 
tissue damage with proinflammatory cytokine production and a 
systemic, anti-inflammatory accelerator of inappropriate migration 
of proinflammatory agents into the blood stream. The main critical 
players of this interaction include the pro-inflammatory cytokines 
IL-1, TNF-alpha, IL-6, IL-8 and metalloproteinases, among others.
Matrix metalloproteinases (MMP) act in processing 
matrix proteins, cytokines, growth factors, and adhesion molecules. 
In addition, it has been reported in the literature that MMPs play a 
role in cell signaling7. Matrix metalloproteinases 2 and 9 are very 
important mediators in tissue inflammatory response and have also 
been implicated in acute lung injury8-10.
The initial management of SAP is supportive based 
on fluid resuscitation, analgesia, enteral nutrition and thrombo-
prophylaxis11. Therefore, effective therapy directed to prevent or 
reverse over-inflammatory response, oxidative stress and intestinal 
barrier damage will be critical and ideal for the development of 
new treatment strategies of SAP and improve its prognosis.
Ethyl pyruvate (EP), a simple derivative of pyruvic acid, 
is also an reactive oxygen species (ROS) scavenger, but seems to 
exert pharmacological effects, such as suppression of inflammation, 
distinct from those exerted by pyruvate anion. Treatment with 
EP has been shown to improve survival and/or ameliorate organ 
dysfunction in a wide variety of pre-clinical models of acute 
illnesses, such as severe sepsis, acute pancreatitis and stroke12-14. 
Therefore, we reasoned that EP might also be protective against 
ALI, acting on inhibition of early and late inflammatory cytokines. 
The present study was designed to evaluate whether EP could be 
beneficial in a rat model of severe acute pancreatitis ALI.
Methods
Experimental protocol
The experimental protocol was approved by the Ethics 
Committee. All animals received care in accordance with the 
criteria outlined in the Guide for the Care and Use of Laboratory 
Animals.
For each experiment, a 28 mM solution of ethyl pyruvate 
was freshly prepared by dissolving the compound in commercially 
available Ringer’s lactate solution (RLS). This solution was called 
Ringer’s ethyl pyruvate solution (REPS). Commercially available 
RLS was used as the control solution. All chemicals were 
purchased from Sigma- Aldrich (St. Louis, MO). 
Forty male Wistar rats, weighing 270-330g, were housed 
in individual cages. Room temperature was kept at 21–22°C, a 12-
hour light-dark cycle was maintained, and all rats were fed standard 
rat chow and water ad libitum. They were fasted overnight before 
surgery. 
Induction of AP
The rats were operated on under aseptic conditions, 
and were anesthetized with subcutaneous ketamine (10 mg/kg) 
and xylazine (8 mg/kg). The pancreas was exteriorized through a 
midline abdominal incision, the proximal bile duct was clamped at 
the level of the liver hilum, and the distal bile duct was cannulated 
using a 19-gauge polyethylene catheter through the duodenal wall 
(Figure 1). AP was induced by intraductal retrograde injection of 
0.5 ml 2.5% sodium taurocholate (Sigma- Chemical Company 
TM , St. Louis, Mo., USA), under pressure control. Injection flow 
was 0.2 ml/min. Previous studies in our laboratory with this model 
have shown a mortality rate of 35% after 72 h10,15. After making 
sure that there was no active bleeding in the abdominal cavity, the 
abdomen was closed in layers.
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FIGURE 1 - Catheter positioned transduodenally, into the pancreatic 
duct of the rat, for infusion of the taurocholate 2.5% and induction of a 
necrotizing pancreatitis.
Study design
The animals were randomized into the following 2 
experimental groups. Treatment was provided after three and six 
hours after AP induction. Rats of CT-group were controls and 
were given intraperitoneal injections of Ringer solution treatment. 
Those in EP-group were submitted to intraperitoneal Ringer ethyl-
pyruvate solution treatment (50mg/kg). The volume of Ringer 
infused in CT group was calculated to present the same amount as 
EP group. No antibiotics were administered before, during, or after 
the procedure. The rats returned to their cages with free access 
to water after surgery. Two hours later, all animals were again 
anesthetized and underwent laparotomy and thoracotomy. The 
thorax was opened, the left atrium was incised, and the lung was 
perfused in situ with PBS via the pulmonary artery. The flushed 
lungs were removed immediately, frozen in liquid nitrogen, and 
stored at -80°C until use. The animals were then, euthanized with 
ketamine overdose. 
In order to study acute lung injury, lung tissue specimen 
were taken for study of the following parameters: interleukin-
1B (IL-1), interleukin-6 (IL-6), interleukin-10 (IL-10), tumoral 
necrosis factor (TNF-a), myeloperoxidase (MPO), maleic-
dialdehyde (MDA), metalloproteinase 2 e 9, nitric oxide and heat 
shock protein 70 (HSP70).
Survival protocol
The second experiment was designed to determine the 
effect on rat survival of treatment with   EP solution (50 mg/
kg). Severe acute pancreatitis was induced the same way and the 
animals were given endovenous fluid resuscitation treatment in 
groups CT and EP. After surgery, rats were housed in a dry and 
clean room at a temperature of 20-26°C, and 12h later standard 
chow and water were freely available. These animals were not re-
operated and were kept to record mortality up to ten days after the 
procedure. Mortality was observed and recorded every day.
Lung tissue preparation
Frozen tissue (100 mg) was pulverized in liquid 
nitrogen with a mortar and pestle. Samples were homogenized 
in radioimmunoprecipitation assay buffer containing 10 mmol/L 
of Tris-HCl (pH 7.5), 1% of Tergitol, 0.1% of sodium dodecyl 
sulfate (SDS), 1% of sodium deoxycholate, 150 mmol/L 
of NaCl, and proteolytic enzyme inhibitors (40 Kg/mL of 
phenylmethylsufonylfluoride and 10 Kg/mL of pepstatin; Sigma). 
After debris separation by centrifugation for 45 minutes at 
14.000g, the supernatants were collected and protein concentration 
was determined by the Bradford method (Bio-Rad Laboratories, 
Hercules, Calif ). Samples were stored at j80-C until assayed. 
Neutrophil Infiltration Myeloperoxidase (MPO) activity 
was used as a marker for tissue PMN infiltration. Lung tissue 
fragments (50 mg) were rinsed with saline and homogenized in 0.1 
mmol/L of sodium phosphate buffer (80 mmol/L of NaH2PO4-
H2O and 80 mmol/L of Na2HPO4-7H2O, pH 5.5) containing 
0.5% of hexadecyl trimethyl ammonium bromide and 10 mmol/L 
of 3N morpholinic) propanesulfonic acid. Suspensions were 
then centrifuged at 14.000g for 30 minutes, and the resulting 
supernatant was collected. Lung MPO activity was assayed in the 
supernatant with a mixture of 20 mcL of the sample and 140 KL 
of 0.1-mmol/L sodium phosphate buffer (pH 5.5). The reaction 
was started by adding 20 KL of 3,5-tetramethylbenzidine liquid 
substrate system (Sigma) and 20 KL of 3% hydrogen peroxide, 
and the samples were incubated for five minutes. The reaction was 
stopped by adding 50 KL of 2N H2SO417,18. The optical density 
(OD) was read at 450 nm in a Tecan GENius plate reader (Tecan, 
Salzburg, Austria).
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Gelatin zymography
Supernatants from tissue preparation were diluted to a 
protein concentration of 1 mg/mL. Twenty-microliter aliquots were 
applied to 10% polyacrylamide gels with 1% gelatin incorporated 
as a substrate for gelatinolytic proteases. After running the gel, 
the SDS was removed by washing the gel twice in 2.5% (vol/
vol) Triton X-100 (Sigma) for 30 minutes. The gel was incubated 
overnight in zymography development buffer containing 50 
mmol/L of Tris-HCl(pH 7.4), 2 mmol/L of NaN3, and 5 mmol/L 
of CaCl2. We added MMP inhibitors (10 mmol/L) of EDTA and 
10 mmol/L of 1,10-phenatroline) to the development buffer to 
assess whether the observed gelatinolytic bandswere caused by 
serine protease activity or MMP activity. After development, the 
gels were stained for 3 hours in 45% methanol/ 10% glacial acetic 
acid containing 1% (wt/vol) Comassie Blue R-250 (Bio-Rad 
Laboratories, Hercules, Calif ) and were subsequently partially 
destained with the same solution without dye. The gelatinolytic 
activity of each MMP was qualitatively evaluated as a clear band 
against the blue-stained gelatin background5,17. Band intensity was 
quantitated using the software Image J (Research Services Branch, 
National Institutes of Health, Bethesda, Md).
Immunoblotting
Protein expression was performed using an SDSY 
polyacrylamide gel electrophoresis under reducing conditions. 
Lung tissue extracts (25Y100 Kg/mL) were boiled in equal 
volumes of loading buffer (150 mmol/L of Tris-HCl, pH 6.8; 4% of 
SDS; 20% of glycerol; 15% of A-mercaptoethanol; and 0.01% of 
bromophenol blue) and were subjected to electrophoresis in 10% 
polyacrilamide gels. After electrophoretic separation, proteins 
were transferred to Hybond-P membranes (Amersham Pharmacia 
Biotech, Buckinghamshire, England). Membranes were blocked 
with 5% nonfat dry milk in Tris-buffered saline and 0.5% Tween 
(TBST) for 1 hour. Primary antibodies against HSPs (polyclonal 
goat antirat, 1:1000; Santa Cruz Biotechnology, Inc, Santa Cruz, 
Calif) were used. Antibodies were incubated at 4-C overnight. 
After washing twice with TBST, secondary antibody horseradish 
peroxidase conjugate (Santa Cruz Biotechnology, Inc) was applied 
at a dilution of 1:1000 for two hours. Blots were washed in TBST 
twice for 30 minutes, incubated in enhanced chemiluminescence 
reagents (SuperSignal detection kit; Pierce, Rockford, Ill), and 
exposed to Kodak O-OMAT-AR photographic film (Kodak, 
Rochester, NY). Band intensity was quantitated using the software 
Image J (Research Services Branch, National Institutes of Health).
Cytokine measurements
The concentrations of TNF-a, IL-6 and IL-1b were 
measured using commercially available enzyme-linked 
immunosorbent assay kits (R&D Systems, Minneapolis, MN) 
according to the manufacturer’s instructions. The sensitivities 
for TNF-a, IL-6 and IL-1b were 15 pg/ml, 5 pg/ml and 5 pg/ml, 
respectively.
MDA
Evaluation of maleic dialdehyde activity was performed 
with samples of pulmonary parenchyma that were collected, 
rinsed in saline buffer, snap-frozen in liquid nitrogen and stored 
at -80°C, until analyzed. MDA contents of the lung were tested 
by enzymatic-spectrophotometric kit (Jian Cheng Biotech Ltd, 
China). The tissue levels of MDA were interpreted as an indicator 
of lipid peroxidation.  All these indexes were examined according 
to the manufacturer’s instructions.
Statistical analysis
Overall survival was calculated by the Kaplan-Meier 
Estimate. The log-rank test and the Chi-square test were used to 
compare survival curves in the two groups. A p value < 0.05 was 
considered statistically significant.
Data were expressed as mean (SEM). Comparisons 
between experimental groups were performed by analysis of 
variance, and the t Student test was used as posttest to compare 
individual group. All analyses were performed using SPSS 
(Statistical Package for the Social Science) 13.0 for Windows.
Results
Macroscopic findings
Autopsies were carried out on dead rats. In all cases, 
much yellow or bloody exudate with a slight smell would come 
out of the peritoneal cavity when the abdomen was opened. The 
gastrointestinal tract was obviously ectatic and edematous. The 
intestine would expand to 2-3 times of normal with gas and fluid 
inside and with a thinner wall. The pancreas was swollen and dark 
colored with some local hemorrhagic spots (Figure 2). Yellow-
white saponified spots were always found in the peripancreatic 
omentum and retroperitoneum. The lower part of the spleen 
was always dark black. A pancreatic or hepatic abscess could be 
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observed if the rat died after the 4th day or later. Compared with 
SAP group, the severity of macroscopic changes was remarkably 
attenuated in the EP group.
FIGURE 2 - At re-laparotomy, the lung was resected and freezed. The 
pancreas was swollen and dark colored with some local hemorrhagic 
spots, revealing an acute necrotizing pancreatitis, induced by the artificial 
bile, taurocholate 2.5%.
Ringer ethyl-pyruvate solution reduces interleukin-6 in 
the lungs
The Table 1 shows the IL-6 measurement following the 
Ringer-EP treatment and the Ringer (CT group).  
TABLE 1 – IL-6 values found in pulmonary specimen, 
with comparison between the two groups.
Group Media Standard deviation Median Minimum Maximum
CT 57.18 38.88 45.65 20.45 155.25
EP 28.54 11.51 29.48 12.39 49.90
As it can be seen in Figure 3, the levels of IL-6 were 
significantly lower in the EP group, when compared to the CT 
group.  t(18)= 2.23; 95%IC= 1.70 a 55.58; p= 0.038.
FIGURE 3 - Boxplot of IL-6 measurement on pulmonary specimen in a 
comparison between groups CT and EP.
Ringer ethyl-pyruvate solution diminishes MMP-2 in the 
Lungs
The MMPs are released upon neutrophil degranulation and 
aid in basement membrane digestion and neutrophil sequestration 
in the lung. Pulmonary MMP-2 activity demonstrated after AP 
was markedly high when compared to the CT group at eight hours. 
There was significant difference in the serum gelatinase 
profiles of the two experimental groups.  The Table 2 shows the 
MMP-2 measurement following the Ringer-EP treatment and the 
Ringer (CT group)
TABLE 2 – Difference of MMP-2 measurement between 
group EP and CT.
Group Media Standard deviation Median Minimum Maximum
CT 25278.80 3086.35 26087.00 20183.00 28528.00
EP 16998.80 2238.73 17100.00 13493.00 19184.00
As it can be seen in Figure 4, the levels of MMP-2 were 
significantly lower in the EP group, when compared to the CT 
group. t(8)= 4.86; 95%IC= 4347.95 a 12212.05; p= 0.001.
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FIGURE 4 - Boxplot of MMP-2 expression comparing both groups (CT 
and EP).
Figure 5 depicts the reduction in matrix metalloproteinase-2 
expression, following EP treatment. No reduction was observed in 
the control group. 
FIGURE 5 - Gelatin zymography was used to assess the effects of EP 
on the MMP-2 activity in the lung tissue. MMP-2 activity significantly 
decreased after eight hours, in the group treated by Ringer-EP solution 
(p=0.001). 
As shown in Tables 3 and 4, no differences were found in 
IL-1B, IL-10, TNF, NO, MPO, MDA and MMP-9. Furthermore, 
EP group animals had levels of HSP70 activity comparable to that 
of the control. Nevertheless, the significant differences between 
groups concerning IL-6 and MMP-2 show an important role of the 
EP in inflammatory response.
TABLE 3 – Biochemical parameters analysis subsequent to Ringer-EP and Ringer solution treatment.
Parameters N Media SD Median Minimum Maximum
CT- group
IL-1 10 86.50 95.18 48.99 29.04 348.19
IL-6 10 57.18 38.88 45.65 20.45 155.25
IL-10 10 265.70 240.02 181.32 112.49 886.29
MDA 10 0.02 0.02 0.02 0.00 0.07
NO 10 2.22 1.88 1.69 0.38 5.83
MPO 10 1.89 3.00 0.78 0.25 10.07
TNF 10 67.10 79.61 33.64 24.05 283.83
MMP-2 5 25278.80 3086.35 26087.00 20183.00 28528.00
MMP-9 5 21345.80 4021.21 19566.00 17105.00 26120.00
HSP 70 5 21736.40 3480.73 21326.00 18984.00 27638.00
EP - group
IL-1 10 76.25 41.01 63.72 46.29 187.62
IL-6 10 28.54 11.51 29.48 12.39 49.90
IL-10 10 148.70 63.23 141.77 60.75 272.46
MDA 10 0.01 0.01 0.01 0.01 0.03
Nitrito 10 4.94 4.36 4.56 0.52 12.35
MPO 10 0.48 0.43 0.27 0.07 1.22
TNF 10 31.95 10.91 28.27 21.22 56.70
MMP-2 5 16998.80 2238.73 17100.00 13493.00 19184.00
MMP-9 5 18760.60 8179.36 20477.00 9243.00 29200.00
HSP 70 5 22959.20 3233.67 22125.00 19778.00 28414.00
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TABLE 4 – t Student test of independent specimen, comparing biochemical data, between groups.
Parameters T DF 95% IC (difference) P
IL-1 0.31 18 -58.61 a 79.11 0.758
IL-6 2.23 18 1.70 a 55.58 0.038*
IL-10 1.49 18 -47.91 a 281.90 0.153
MDA 1.31 18 0.00 a 0.02 0.206
Nitrito -1.81 18 -5.87 a 0.44 0.088
MPO 1.47 18 -0.61 a 3.41 0.160
TNF 1.38 18 -18.23 a 88.54 0.183
MMP-2 4.86 8 4347.95 a 12212.05 0.001*
MMP-9 0.63 8 -6814.25 a 11984.65 0.544
HSP 70 -0.58 8 -6122.40 a 3676.80 0.581
Ethyl pyruvate improves survival in rats with acute 
pancreatitis
As expected, all ten of the rats in the control group died 
until the third day of severe AP induction (Figure 6). In contrast, in 
the group with pancreatitis treated with Ringer-EP, only one of ten 
animals (10%) reached the tenth days of this period of observation. 
Seven of ten (70%) rats in the EP group survived after the third 
day. Survival time was significantly longer in the EP group than 
the CT group (p = 0.011).
FIGURE 6 - Kaplan-Meier survival curves of SAP rats. 1: Control group; 
2: EP treatment group. Administration of EP dose prevents the lethality 
of ALI. Survival curves (50 mg/kg/d) of EP versus survival in vehicle-
treated controls (CT); p = 0.01 by log-rank test.
Table 5 details de survival findings after statistical 
evaluation. Animals from the EP group had improved survival 
after necrotizing acute pancreatitis induction.
TABLE 5 – Comparison of Kaplan-Meier survival 
curve, after ten days.
Group Frequency (%) X
2 GL P
CT 100 11.23 1 0.001*
EP 100
Discussion
The pathophysiological events in experimental acute 
pancreatitis consists of activation of pancreatic enzymes within 
acinar cells, the release of these activated enzymes in the 
interstitial, the autodigestion of the pancreas, and the release of 
activated pancreatic enzymes and other factors into the circulation 
that result in the development of multiple organ dysfunction. 
Currently, the factors that determine the ultimate severity of the 
acute pancreatitis remain uncertain16. 
ALI is the most common and severe complication of SAP 
during the early stage. About one third of patients with SAP may 
develop acute lung injury, which is manifested clinically as acute 
respiratory distress syndrome (ARDS). During the first week, 
approximately 20% patients with acute lung injury develop ARDS. 
It is the first cause of patients’ death during the early stage17. 
The initial clinical response to pancreatitis is a systemic 
inflammatory response (SIRS), which, if abnormally persistent, 
develops into a worsening scenario of tissue damage and sepsis 
resulting in multiple organ dysfunction syndrome (MODS)18-20. 
These pathological changes in the pancreatic gland 
are responsible for releasing active pancreatic enzymes into the 
bloodstream and stimulating the production of inflammatory 
cytokines such as interleukin-1, interleukin-6 and interleukin-8 
from neutrophils, macrophages and lymphocytes. The release 
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of those interleukins and tumor necrosis factor-α (TNF-α) from 
macrophages triggers an inflammatory cascade, which leads to the 
systemic inflammatory response syndrome (SIRS)11.
The critical players of this interaction include the pro-
inflammatory cytokines IL-1beta, TNF-alpha, IL-6, interleukin-10 
(IL-10), neutrophils infiltration, lipidic peroxidation 
metalloproteinase 2 e 9, nitric oxide and heat shock protein 70 
(HSP70)10.
Despite several experimental models of severe acute 
pancreatitis have been reported, one of the best-standardized 
compounds to use is sodium taurocholate. Infusion of 0.2 ml/kg of 
3%, 4.5% or 5% solution induced acute haemorrhagic pancreatitis 
with 72-h mortality rates of 24%, 71% and 100%, respectively. 
This model is appropriate for studies of systemic issues.
EP administration significantly improves the survival of 
lethal hemorrhagic shock in standard models, and significantly 
inhibits the systemic release of both early (TNF-α) and late 
(HMGB1) cytokines that mediate the lethality of sepsis and 
systemic inflammation, even when administered 24 h after cecal 
puncture. 
The pharmacologic mechanisms responsible for the anti-
inflammatory effects of ethyl pyruvate remain poorly understood. 
It is known, however, that pyruvate reacts non-enzymatically to 
scavenge the reactive oxygen species (ROS) hydrogen peroxide. 
Thus, it is conceivable that the beneficial effects of ethyl pyruvate 
are due to its properties as an antioxidant. Interestingly, however, 
recent observations from our laboratory suggest that ROS 
scavenging is unlikely to be the entire explanation for the anti-
inflammatory properties of ethyl pyruvate. The reduction on 
MMP-2 levels may lead to another role of the EP in ameliorating 
the inflammatory cascade of severe AP.
Cytokines
It is likely that pro-inflammatory cytokines, notably 
TNF-a, IL-1b and IL-6, participate in the early development of 
inflammation; they have been shown to play a crucial role in ALI 
and ARDS. Since cytokines could play an important role in AP, 
many agents have been used in experimental animals to ameliorate 
or prevent the inappropriate activation of the immune systems. 
In our study, IL-6 were significantly reduced in the EP 
group. However, the other cytokines presented no significant 
alterations throughout the research. The following results 
were found in the measurements of IL-1B, IL-10 and TNF-a, 
respectively: p=0.758, p= 0.153 and p= 0.183.
IL-6 levels are elevated in pancreatitis and serve as 
markers of severity of pancreatitis, in addition to paralleling the 
course of the disease. IL-6 levels can also help to predict the 
possibility of pulmonary complications. In this aspect, IL-6 is 
superior to C-Reactive protein or B-2 microglobulin and has been 
shown to rise 12–24h before other inflammatory markers.
Matrix metalloproteinases
The matrix metalloproteinases (MMPs) are believed 
to be the main physiological mediators of ECM degradation. In 
adult tissue, low level MMP expression mediates normal matrix 
remodeling, while during inflammation and injury, large amounts 
of MMPs are produced presumably to repair damaged ECM. By 
cleaving ECM components, MMPs could play a role in the repair 
of the alveolar epithelium during acute lung injury. Gelatinases, 
MMP-2 and MMP-9, are known to degrade almost all basement 
membrane constituents, including type IV collagen, nidogen and 
laminin, and gelatins.
Matrix metalloproteinases 2 and 9 are important mediators 
in tissue inflammatory response and have also been implicated in 
lung injury8. Elevated MMP activity in this study in demonstrated 
by gelatin zymography and confirmed by the fluorogenic substrate. 
Extracellular matrix degradation from MMP-2 and MMP-9 may 
result in capillary leak and play a causative role in the lung injury. 
In acute pancreatitis, the role of polymorphonuclear 
neutrophils (PMNs) for alveolar membrane dysfunction and lung 
injury has been clarified before. MMP-2 is synthesized by a wide 
variety of cells, including fibroblasts, endothelial cells and alveolar 
epithelial cells. Elevated levels of active MMP-2 have been shown 
to be a specific pulmonary response during ARDS, independent 
of other organ failures. Our findings of a significant reduction in 
MMP-2 in the EP group may explain the survival improvement 
observed during the second experiment. We cannot explain the 
reason for the not altered measurement of MMP-9, indeed.
Although the manipulations of specific mediators in 
animal models may be promising, they may not transition well 
to the human clinical setting. However, continued reliance on 
experimental animal models of acute pancreatitis may be necessary 
to determine the underlying causes of disease. Measurement of 
the inflammatory response may also serve to identify diagnostic 
markers for the presence of acute pancreatitis and provide insight 
into prognosis. Understanding the models, documenting the 
markers, and deciphering the mediators have the potential to 
improve treatment of acute pancreatitis.
Our data showed that administration of EP even when 
initiated 3h after induction of ALI significantly increased survival. 
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The levels of the IL-6 had decreased significantly. The expression 
of MMP-2 was also significantly affected; indicating that EP 
modulation of inflammatory cytokines contributes to the beneficial 
effects on survival.
Conclusions
Ethyl-pyruvate (EP) treatment in established severe 
acute pancreatitis (SAP) lung injury reduced the severity of AP 
and the mortality rate in an animal model of SAP. These findings 
suggest that EP strategies are of potential therapeutic value in the 
treatment of associated lung injury (ALI) in severe AP.
References
1. McKay CJ, Imrie CW. The continuing challenge of early mortality 
in acute pancreatitis. Br J Surg. 2004;91:1243-4.
2. Gloor B, Müller CA, Worni M, Martignoni ME, Uhl W, Büchler 
MW. Late mortality in patients with severe acute pancreatitis. Br J 
Surg. 2001;88:975-9.
3. Chen YP, Ning JW, Ji F. Establishment of the critical period of severe 
acute pancreatitis-associated lung injury. Hepatobiliary Pancreat Dis 
Int. 2009;8(5):535-40.
4. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J 
Hepatobiliary Pancreat Surg. 2002;9:401-10. 
5. Pereda J, Sabater L, Cassinello N, Gómez-Cambronero L, Closa 
D, Folch-Puy E, Aparisi L, Calvete J, Cerdá M, Lledó S, Viña J, 
Sastre J. Effect of simultaneous inhibition of TNF-alpha production 
and xanthine oxidase in experimental acute pancreatitis: the role of 
mitogen activated protein kinases. Ann Surg. 2004;240:108-16.
6. Gomez-Cambronero LG, Sabater L, Pereda J, Cassinello N, Camps 
B, Viña J, Sastre J. Role of cytokines and oxidative stress in the 
pathophysiology of acute pancreatitis: therapeutical implications. 
Curr Drug Targets Inflamm Allergy. 2002;1:393-403.
7. Okamoto T, Akuta T, Tamura F, van Der Vliet A, Akaike T. 
Molecular mechanism for activation and regulation of matrix 
metalloproteinases during bacterial infections and respiratory 
inflammation. Biol Chem. 2004;385(11):997-1006.
8. Muhs BE, Patel S, Yee H, Yee H, Marcus S, Shamamian P. 
Inhibition of matrix metalloproteinases reduces local and distant 
organ injury following experimental acute pancreatitis. J Surg Res. 
2003;109(2):110-7.
9. Steinberg J, Halter J, Schiller HJ, Dasilva M, Landas S, Gatto 
LA, Maisi P, Sorsa T, Rajamaki M, Lee HM, Nieman GF. 
Metalloproteinase inhibition reduces lung injury and improves 
survival after cecal ligation and puncture in rats. J Surg Res. 
2003;111(2):185-95.
10. Moretti AI, Rios EC, Soriano FG, de Souza HP, Abatepaulo F, 
Barbeiro DF, Velasco IT. Acute pancreatitis: hypertonic saline 
solution increases heat shock proteins 70 and 90 and reduces 
neutrophil infiltration in lung injury. Pancreas. 2009;38(5):507-14.
11. Tonsi AF, Bacchion M, Crippa S, Malleo G, Bassi C. Acute 
pancreatitis at the beginning of the 21st century: the state of the art. 
World J Gastroenterol. 2009;15:2945-59.
12. Kao KK, Fink MP. The biochemical basis for the anti-inflammatory 
and cytoprotective actions of ethyl pyruvate and related compounds. 
Biochem Pharmacol. 2010;80(2):151-9.
13. Fink MP. Ethyl pyruvate: a novel anti-inflammatory agent. J Intern 
Med. 2007;261(4):349-62. 
14. Zingarelli B. Ethyl pyruvate: a simple solution? Crit Care Med. 
2004;32(7):1603-4. 
15. Machado MC, Coelho AM, Pontieri V, Sampietre SN, Molan 
NA, Soriano F, Matheus AS, Patzina RA, Cunha JE, Velasco IT. 
Local and systemic effects of hypertonic solution (NaCl 7.5%) in 
experimental acute pancreatitis. Pancreas. 2006;32:80–6.
16. Su KH, Cuthbertson C, Christophi C. Review of experimental 
animal models of acute pancreatitis. HPB (Oxford). 2006;8:264-86.
17. Kan SH, Huang F, Tang J, Gao Y, Yu CL. Role of intrapulmonary 
expression of inducible nitric oxide synthase gene and nuclear factor 
kappaB activation in severe pancreatitis-associated lung injury. 
Inflammation. 2010;33(5):287-94.
18. Davies MG, Hagen PO. Systemic inflammatory response syndrome. 
Br J Surg. 1997;84:920–35.
19. Ware LB, Matthay MA. The acute respiratory distress syndrome. N 
Engl J Med. 2000;342:1334-49.
20. Malangoni MA, Martin AS. Outcome of severe acute pancreatitis. 
Am J Surg. 2005;189:273-7.
Acknowledgments
To Postgraduate Program in Gastrointestinal Division, 
Federal University of Sao Paulo, Prof. Dr. Heraldo Possolo de 
Souza and Prof. Dr. Irineu Tadeu Velasco for technical assistance 
and advice on the Emergency Medicine Lab, LIM 51, USP, Brazil.
Correspondence:
Dr. Jacques Matone
Avenida Angélica, 2503/66 
01227-200  São Paulo – SP  Brasil
Tel.: (55 11)3257-2398
Fax: (55 11)3237-4818
matone@einstein.br
Received: April 18, 2013
Review: June 20, 2013
Accepted: July 22, 2013
Conflict of interest: none 
Financial sources: The research was financed by the Postgraduate Program 
in Gastrointestinal Surgery (UNIFESP-EPM) and Emergency Medicine 
Lab – LIM51 (USP).
1Research performed at Experimental Laboratory of Emergency Medicine, 
LIM51, University of Sao Paulo (USP), Brazil. Part of PhD degree thesis, 
Postgraduate Program in Gastrointestinal Surgery, Federal University 
of Sao Paulo – Paulista Medical School (UNIFESP-EPM), Sao Paulo, 
Brazil. Tutor: Prof. Alberto Goldenberg.
